Connection

Charles Swanton to Middle Aged

Back to Details
This is a "connection" page, showing publications Charles Swanton has written about Middle Aged.
Charles Swanton
Connection Strength
0.061
Middle Aged
  1. BCL9L Dysfunction Impairs Caspase-2 Expression Permitting Aneuploidy Tolerance in Colorectal Cancer. Cancer Cell. 2017 01 09; 31(1):79-93.
    View in: PubMed
    Score: 0.011
  2. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021 07 17; 398(10296):207-209.
    View in: PubMed
    Score: 0.004
  3. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 06 19; 397(10292):2331-2333.
    View in: PubMed
    Score: 0.004
  4. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020 12 11; 370(6522):1339-1343.
    View in: PubMed
    Score: 0.004
  5. Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy. Epilepsy Behav. 2021 02; 115:107602.
    View in: PubMed
    Score: 0.004
  6. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020 08; 21(8):1035-1044.
    View in: PubMed
    Score: 0.004
  7. Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol. 2020 08; 31(8):1065-1074.
    View in: PubMed
    Score: 0.004
  8. Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts. J Thorac Oncol. 2019 11; 14(11):1935-1947.
    View in: PubMed
    Score: 0.003
  9. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. Lancet Oncol. 2019 04; 20(4):518-530.
    View in: PubMed
    Score: 0.003
  10. Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal. Cell. 2018 04 19; 173(3):595-610.e11.
    View in: PubMed
    Score: 0.003
  11. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell. 2018 04 19; 173(3):581-594.e12.
    View in: PubMed
    Score: 0.003
  12. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Cancer Cell. 2018 05 14; 33(5):843-852.e4.
    View in: PubMed
    Score: 0.003
  13. Expansion of airway basal epithelial cells from primary human non-small cell lung cancer tumors. Int J Cancer. 2018 07 01; 143(1):160-166.
    View in: PubMed
    Score: 0.003
  14. Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study. J Clin Oncol. 2018 02 20; 36(6):536-542.
    View in: PubMed
    Score: 0.003
  15. Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis. Neuro Oncol. 2017 Aug 01; 19(8):1058-1067.
    View in: PubMed
    Score: 0.003
  16. Spatial heterogeneity in medulloblastoma. Nat Genet. 2017 May; 49(5):780-788.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.